Genetic and epigenetic control of the major histocompatibility complex class Ib Gene HLA-G in Trophoblast cell lines

Annals of the New York Academy of Sciences

Volumn 1173, Issue , 2009, Pages 538-544

  Holling, Tjadine M ^a   Bergevoet, Marloes W T ^a   Wierda, Rutger J ^a   Van Eggermond, Marja C J A ^a   Van Den Elsen, Peter J ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

DNA methylation; Epigenetics; Histone acetylation; HLA G; Trophoblast cells

Indexed keywords

HISTONE; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ACETYLATION; ANTIGEN EXPRESSION; CELL LINE; CHORIOCARCINOMA; CHROMATIN IMMUNOPRECIPITATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTROPHOBLAST; DNA METHYLATION; GENE EXPRESSION; GENETIC EPIGENESIS; GENETIC REGULATION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SEQUENCE; PROMOTER REGION; TRANSCRIPTION INITIATION; TROPHOBLAST;

EID: 70049107371     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04660.x     Document Type: Conference Paper

References (27)

1. Van Den Elsen, P.J. et al. 2004. Transcriptional regulation of antigen presentation. Curr. Opin. Immunol. 16: 67-75.
2. Gobin, S.J.P. & P.J. Van Den Elsen. 2000. Transcrip-tional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. Hum. Immunol. 61: 1102-1107.
3. Braud, V.M., D.S. Allan & A.J. McMichael. 1999. Functions of nonclassical MHC and non-MHC-encoded class I molecules. Curr. Opin. Immunol. 11: 100-108.
4. Le Bouteiller, P. & C. Solier. 2001. Is antigen presentation the primary function of HLA-G? Microbes. Infect. 3: 323-332.
5. Moreau P., J. Lemaoult & N. Rouas-Freiss. 2008. HLA-G: from biology to clinical benefits. Trends Immunol. 29: 125-132.
6. Rouas-Freiss, N. et al. 2007. Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses. Semin. Cancer Biol. 17: 413-421.
7. Carosella, E.D. et al. 2008. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 111: 4862-4870.
8. Wiendl, H. et al. 2005. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 128: 2689-2704.
9. Fainardi, E. et al. 2006. Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Mult. Scler. 12: 2-12.
10. Holling, T.M. et al. 2002. Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III. J. Immunol. 168: 763-770.
11. Wong, A.W. et al. 2002. Regulation and specificity of MHC2TA promoter usage in human primary T lymphocytes and cell line. J. Immunol. 169: 3112-3119.
12. Le Bouteiller, P. & F. Lenfant. 1996. Antigen-presenting function(s) of the non-classical HLA-E,-F and-G class I molecules: the beginning of a story. Res. Immunol. 147: 301-313.
13. Apps, R. et al. 2008. A critical look at HLA-G. Trends Immunol. 29: 313-321.
14. O'Callaghan, C.A. & J.I. Bell. 1998. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 163: 129-138.
15. King, A. et al. 2000. HLA-E is expressed on tro-phoblast and interacts with CD94/NKG2 receptors on decidual NK cells. Eur. J. Immunol. 30: 1623-1631.
16. Gobin, S.J.P. et al. 2002. HLA-G transactivation by cAMP-response element-binding protein (CREB). An alternative transactivation pathway to the conserved major histocompatibility complex (MHC) class I regulatory routes. J. Biol. Chem. 277: 39525-39531.
17. Gobin S.J.P. et al. 1997. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transac-tivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 6: 601-611.
18. Martin, B.K. et al. 1997. Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 6: 591-600.
19. Morris, A.C., W.E. Spangler & J.M. Boss. 2000. Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control. J. Immunol. 164: 4143-4149.
20. Van Den Elsen, P.J. et al. 2000. Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methy-lation of the IFN-gamma inducible promoter (PIV) of CIITA. Hum. Immunol. 61: 850-862.
21. Van Der Stoep, N. et al. Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines. Int. J. C a n c e r 97: 501-507.
22. Li, L.C. & R. Dahiya. 2002. MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431.
23. Holling, T.M. et al. A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma. J. Immunol. 179: 5317-5325.
24. Guillaudeux, T. et al. 1995. Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta. J. Immunol. 154: 3283-3299.
25. Onno, M. et al. 1997. CpG methylation patterns in the 5' part of the nonclassical HLA-G gene in peripheral blood CD34+cells and CD2+lymphocytes. Tissue Antigens 49: 356-364.
26. Polakova, K. et al. 2007. Modulation of HLA-G expression. Neoplasma 54: 455-462.
27. Carosella, E.D. et al. 2008. HLA-G-dependent suppressor cells: Diverse by nature, function, and significance. Hum. Immunol. 69: 700-707.